130 related articles for article (PubMed ID: 12117039)
21. Bronchodilating effects of salbutamol from a novel inhaler Airmax.
Middle MV; Terblanché J; Perrin VL; Hertog MG
Respir Med; 2002 Jul; 96(7):493-8. PubMed ID: 12194632
[TBL] [Abstract][Full Text] [Related]
22. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.
Chege JK; Chrystyn H
Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479
[TBL] [Abstract][Full Text] [Related]
23. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
[TBL] [Abstract][Full Text] [Related]
24. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
Fyrnys B; Stang N; Wolf-Heuss E
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
[TBL] [Abstract][Full Text] [Related]
25. Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler.
Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
J Aerosol Med; 2002; 15(4):427-33. PubMed ID: 12581509
[TBL] [Abstract][Full Text] [Related]
26. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions.
Borgström L; Asking L; Lipniunas P
J Aerosol Med; 2005; 18(3):304-10. PubMed ID: 16181005
[TBL] [Abstract][Full Text] [Related]
27. A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler.
Prime D; Grant AC; Slater AL; Woodhouse RN
J Aerosol Med; 1999; 12(2):75-84. PubMed ID: 10539710
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting the efficiency of aerosolized salbutamol delivery via a metered dose inhaler and equine spacer device.
Pirie RS; McGorum BC; Owen C; Carr O; Oakley H; McLachlan G
J Vet Pharmacol Ther; 2017 Jun; 40(3):231-238. PubMed ID: 27593413
[TBL] [Abstract][Full Text] [Related]
29. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
Tarsin WY; Pearson SB; Assi KH; Chrystyn H
Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
[TBL] [Abstract][Full Text] [Related]
30. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser.
Silkstone VL; Corlett SA; Chrystyn H
Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799
[TBL] [Abstract][Full Text] [Related]
31. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
32. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
Smith KJ; Chan HK; Brown KF
J Aerosol Med; 1998; 11(4):231-45. PubMed ID: 10346666
[TBL] [Abstract][Full Text] [Related]
33. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates.
Newhouse MT; Nantel NP; Chambers CB; Pratt B; Parry-Billings M
Chest; 1999 Apr; 115(4):952-6. PubMed ID: 10208191
[TBL] [Abstract][Full Text] [Related]
34. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
35. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
Chambers F; Ludzik A
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
[TBL] [Abstract][Full Text] [Related]
36. Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.
Zhou Y; Brasel TL; Kracko D; Cheng YS; Ahuja A; Norenberg JP; Kelly HW
Pharm Dev Technol; 2007; 12(4):353-9. PubMed ID: 17763140
[TBL] [Abstract][Full Text] [Related]
37. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler.
Wilkes W; Fink J; Dhand R
J Aerosol Med; 2001; 14(3):351-60. PubMed ID: 11693847
[TBL] [Abstract][Full Text] [Related]
38. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
Rau JL; Torniainen M
Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
[TBL] [Abstract][Full Text] [Related]
39. Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.
Lööf T; Elfman P; Ström P; Törngren A; Borgström L
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):381-8. PubMed ID: 18823260
[TBL] [Abstract][Full Text] [Related]
40. Effects of 4-week treatment with low-dose budesonide (100 micrograms BID) from a novel inhaler Airmax and from a conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in patients with mild asthma.
Frew AJ; Langley SJ; Perrin V; Hertog MG
Respir Med; 2002 Jul; 96(7):542-7. PubMed ID: 12194641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
